Middle East & Africa Tissue Diagnostics Market Size & Outlook
Middle East & Africa tissue diagnostics market, 2018-2030 (US$M)
Related Markets
MEA tissue diagnostics market highlights
- The MEA tissue diagnostics market generated a revenue of USD 194.5 million in 2023.
- The market is expected to grow at a CAGR of 5.4% from 2024 to 2030.
- In terms of segment, immunohistochemistry was the largest revenue generating technology in 2023.
- Digital Pathology and Workflow is the most lucrative technology segment registering the fastest growth during the forecast period.
- Country-wise, South Africa is expected to register the highest CAGR from 2024 to 2030.
MEA data book summary
| Market revenue in 2023 | USD 194.5 million |
| Market revenue in 2030 | USD 280.6 million |
| Growth rate | 5.4% (CAGR from 2023 to 2030) |
| Largest segment | Immunohistochemistry |
| Fastest growing segment | Digital Pathology and Workflow |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Immunohistochemistry, In situ Hybridization, Primary & Special Staining, Digital Pathology and Workflow, Anatomic Pathology, Molecular Pathology |
| Key market players worldwide | Roche Holding AG ADR, Abbott Laboratories, Thermo Fisher Scientific Inc, Siemens AG, Danaher Corp, BioMerieux SA, Qiagen NV, BD, Merck KGaA, GE Aerospace, Agilent Technologies Inc, Biogenex, Cell Signaling Technology, Bio SB, DiaGenic |
Other key industry trends
- In terms of revenue, MEA region accounted for 2.4% of the global tissue diagnostics market in 2023.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 2,805.4 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Tissue Diagnostics Market Scope
Tissue Diagnostics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Middle East & Africa tissue diagnostics market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to tissue diagnostics market will help companies and investors design strategic landscapes.
Immunohistochemistry was the largest segment with a revenue share of 25.71% in 2024. Horizon Databook has segmented the Middle East & Africa tissue diagnostics market based on immunohistochemistry, in situ hybridization, primary & special staining, digital pathology and workflow, anatomic pathology, molecular pathology covering the revenue growth of each sub-segment from 2018 to 2030.
Cancer is a major public health concern in this region. High mortality due to unavailability of resources, such as diagnostics; underdeveloped healthcare infrastructure; and lack of affordable treatment options increases the risk of developing cancer. However, lower adoption rate is anticipated to impede the market growth to some extent in this country in the coming years.
Reasons to subscribe to Middle East & Africa tissue diagnostics market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Middle East & Africa tissue diagnostics market databook
-
Our clientele includes a mix of tissue diagnostics market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Middle East & Africa tissue diagnostics market , including forecasts for subscribers. This continent databook contains high-level insights into Middle East & Africa tissue diagnostics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
MEA tissue diagnostics market size, by country, 2018-2030 (US$M)
Middle East & Africa Tissue Diagnostics Market Outlook Share, 2024 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
